Folic acid antagonists during pregnancy and risk of birth defects.
Newman
R D
RD
Parise
M
M
Nahlen
B
B
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000962:Antimalarials / Q000009:adverse effects; D004338:Drug Combinations; D005260:Female; D005493:Folic Acid Antagonists / Q000009:adverse effects*; D006801:Humans; D008288:Malaria / Q000188:drug therapy; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000188:drug therapy; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D011739:Pyrimethamine / Q000009:adverse effects*; D013413:Sulfadoxine / Q000009:adverse effects*
D000962:Antimalarials; D004338:Drug Combinations; D005493:Folic Acid Antagonists; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine